PTSD & Trauma
Navigated TMS Added to Residential Therapy for Combat-Related PTSD
Grade A-Randomized, sham-controlled trial2026
What did this study find?
In this blinded trial, 119 military personnel and veterans with combat-related PTSD received 30 days of intensive residential therapy plus either navigated TMS or sham. Both groups improved. At the end of treatment, the active TMS group showed greater symptom relief than sham on both PTSD measures. TMS is a clinical procedure distinct from consumer PEMF devices.
What are the details of this record?
- Full citation
- Fox PT, Salinas FS, Roache JD, et al. Residential Therapy With Navigated Transcranial Magnetic Stimulation for Combat-Related PTSD: A Randomized Clinical Trial. JAMA Netw Open. 2026;9(4):e265110. doi:10.1001/jamanetworkopen.2026.5110.
- Journal
- JAMA Network Open
- Authors
- Fox PT, Salinas FS, Roache JD, Quinones M, Vaughan PW, Franklin C, Straud CL, Price L, Unzueta-Hernandez M, Woolsey MK, Chavez AM, Hoselton DA, Brundige AR, Litz BT, Young-McCaughan S, Keane TM, Peterson AL; Consortium to Alleviate PTSD
- Study design
- Randomized, sham-controlled trial
- Sample size and population
- 119 active-duty military personnel and veterans (60 active TMS, 59 sham)
- Evidence grade
- Grade A- on the BioReg grading scale
- Reported findings
- Patients, staff and assessors were blinded. Navigated TMS added to 30 days of residential therapy produced greater PTSD symptom relief than sham at end of treatment (PCL-5 difference -5.94, 95% CI -11.77 to -0.10; CAPS-5 difference -6.03, 95% CI -10.84 to -1.22). Both arms improved from baseline. Transcranial magnetic stimulation is a clinical procedure; findings do not transfer directly to PEMF devices.
- Funding and conflicts of interest
- The paper's conflict of interest disclosures read, in part: "Dr Fox reported receiving grants from the US Department of Defense (DoD) Consortium to Alleviate PTSD during the conduct of the study, having a patent for navigated transcranial magnetic stimulation for posttraumatic stress disorder (PTSD) treatment licensed to Cerebral Magnetics, and having equity in Cerebral Magnetics. Prof Salinas reported receiving grants from the DoD and US Department of Veterans Affairs (VA) during the conduct of the study; receiving personal fees from Cerebral Magnetics outside the submitted work; and having a patent for Fox PT system, apparatus, and methods for image-guided, robotically delivered transcranial magnetic stimulation treatment."
- PubMed
- PMID 41945348
- Related categories
- PTSD & Trauma (category grade D to A- (TMS) / B to A- (HRV biofeedback) / F (PEMF))
A positive PEMF study is not evidence for a specific device unless the signal parameters studied, frequency, intensity, waveform, and exposure duration, are reasonably comparable to what that device produces. Where this record does not list those parameters, the source report did not publish them. See the grading methodology. Library last reviewed 2026-08-27.